Youliang Wu

699 total citations
27 papers, 542 citations indexed

About

Youliang Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Youliang Wu has authored 27 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Youliang Wu's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers) and Ferroptosis and cancer prognosis (3 papers). Youliang Wu is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers) and Ferroptosis and cancer prognosis (3 papers). Youliang Wu collaborates with scholars based in China, United States and Sweden. Youliang Wu's co-authors include Yongxiang Li, Ruochuan Sun, Shangxin Zhang, Mingliang Wang, Liwei Su, Wei Zhai, Xiaoming Sun, Weidong Sun, Fang Zheng and Tao Zhang and has published in prestigious journals such as Molecular Cancer, Food Research International and Oncotarget.

In The Last Decade

Youliang Wu

26 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youliang Wu China 12 288 196 97 92 79 27 542
Ruizhi Wang China 9 116 0.4× 25 0.1× 10 0.1× 25 0.3× 41 0.5× 23 333
Guowei Shi China 16 442 1.5× 174 0.9× 8 0.1× 9 0.1× 150 1.9× 56 690
Yuki Toda Japan 12 246 0.9× 77 0.4× 9 0.1× 3 0.0× 26 0.3× 36 423
Lintao Jia China 15 295 1.0× 111 0.6× 5 0.1× 2 0.0× 38 0.5× 24 505
Eskandar Taghizadeh Iran 14 230 0.8× 85 0.4× 28 0.3× 22 0.3× 35 492
Guangjing Zhu United States 11 340 1.2× 73 0.4× 28 0.3× 67 0.8× 17 512
Sandeep R. Bhave United States 7 209 0.7× 66 0.3× 34 0.4× 21 0.3× 11 455
Yubo Ren China 12 152 0.5× 58 0.3× 19 0.2× 84 1.1× 34 421
Hongqing Cao China 8 127 0.4× 69 0.4× 6 0.1× 9 0.1× 5 0.1× 17 277
Tania Islam Bangladesh 13 365 1.3× 89 0.5× 7 0.1× 90 1.1× 19 588

Countries citing papers authored by Youliang Wu

Since Specialization
Citations

This map shows the geographic impact of Youliang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youliang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youliang Wu more than expected).

Fields of papers citing papers by Youliang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youliang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youliang Wu. The network helps show where Youliang Wu may publish in the future.

Co-authorship network of co-authors of Youliang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Youliang Wu. A scholar is included among the top collaborators of Youliang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youliang Wu. Youliang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Xuan, Liming Cheng, Youliang Wu, et al.. (2024). Outcome predictors in patients with temporal lobe epilepsy after temporal resective surgery. PubMed. 6(1). 43–43. 1 indexed citations
2.
Xu, Xin, Yaxian Li, Youliang Wu, et al.. (2022). Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer. Redox Biology. 59. 102564–102564. 64 indexed citations
3.
Cheng, Junwen, Yanbin Wang, Hailong Wei, et al.. (2022). Conformation and anticancer activity of a novel mannogalactan from the fruiting bodies of Sanghuangporus sanghuang on HepG2 cells. Food Research International. 156. 111336–111336. 20 indexed citations
4.
Xie, Xuemin, et al.. (2022). Polysaccharides, Next Potential Agent for the Treatment of Epilepsy?. Frontiers in Pharmacology. 13. 790136–790136. 7 indexed citations
5.
Yan, Qiang, et al.. (2022). A-Kinase Anchoring Protein 9 Promotes Gastric Cancer Progression as a Downstream Effector of Cadherin 1. Journal of Oncology. 2022. 1–7. 1 indexed citations
6.
Wu, Youliang, et al.. (2022). Pathophysiology and Clinical Management of Autoimmune Encephalitis-Associated Seizures. NeuroImmunoModulation. 29(4). 282–295. 4 indexed citations
7.
Wu, Youliang, et al.. (2021). Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells. BMC Cancer. 21(1). 433–433. 7 indexed citations
8.
Wang, Huizhen, et al.. (2021). Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance. Journal of Molecular Medicine. 99(2). 193–212. 18 indexed citations
9.
Wu, Youliang, Mingliang Wang, Xiaodong Wang, et al.. (2021). A signature of seven immune‐related genes predicts overall survival in male gastric cancer patients. Cancer Cell International. 21(1). 117–117. 11 indexed citations
10.
Li, Cong, Wenyu Li, Shuang Dai, et al.. (2021). Targeted therapy with anlotinib for a leptomeningeal spread recurrent glioblastoma patient. Progress in brain research. 265. 407–414. 2 indexed citations
11.
Wang, Huizhen, et al.. (2021). Correction to: Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance. Journal of Molecular Medicine. 99(7). 1021–1022. 2 indexed citations
12.
Wang, Mingliang, et al.. (2021). High ATF4 Expression Is Associated With Poor Prognosis, Amino Acid Metabolism, and Autophagy in Gastric Cancer. Frontiers in Oncology. 11. 740120–740120. 28 indexed citations
13.
Wang, Mingliang, Cheng Wu, Xin Xu, et al.. (2021). Development and Validation of a Prognostic Nomogram for Gastric Marginal Zone Lymphoma: a Surveillance, Epidemiology and End Results-based population Study. Future Oncology. 17(5). 529–539. 2 indexed citations
14.
Wu, Youliang, Jiajie Mo, Jianguo Zhang, et al.. (2021). Deep Brain Stimulation in Treatment-Resistant Depression: A Systematic Review and Meta-Analysis on Efficacy and Safety. Frontiers in Neuroscience. 15. 655412–655412. 51 indexed citations
15.
Wu, Youliang, Delong Meng, Ruochuan Sun, et al.. (2020). Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma. Oncology Reports. 44(1). 55–68. 11 indexed citations
16.
Wu, Youliang, et al.. (2020). Synchronization to auditory and visual beats in Parkinson's disease. Parkinsonism & Related Disorders. 79. 47–54. 3 indexed citations
17.
Wu, Youliang, Delong Meng, Ruochuan Sun, et al.. (2020). Hypoxia Inducible Factor-1alpha (HIF-1A) plays different roles in Gallbladder Cancer and Normal Gallbladder Tissues. Journal of Cancer. 12(3). 827–839. 6 indexed citations
18.
Zheng, Fang, Shuai Yin, Ruochuan Sun, et al.. (2017). miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1. Molecular Cancer. 16(1). 139–139. 114 indexed citations
19.
Zhang, Tao, Youliang Wu, Fang Zheng, et al.. (2016). Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer.. PubMed. 6(11). 2679–2689. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026